Elevance Health annual meeting: directors elected, say-on-pay approved, two shareholder proposals defeated

Elevance Health, Inc.

All four director nominees elected with >96% of votes cast; terms expire 2026.
Advisory vote on executive compensation approved with 187.5M for (93.6% of votes cast).
Shareholder proposal for special meeting rights (10% threshold) not approved: 91.7M for vs 107.7M against.
Shareholder proposal on third-party reporting rejected: 16.1M for vs 181.8M against.
Ratification of Ernst & Young as auditor for 2023 passed with 197.1M for (92.3% of votes cast).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.